Some have applied for the synergistic formula of dimethyl sulfone and dimethyl sulfoxide or dimethyl sulfoxide, dimethyl sulfoxide and oxidized purinol (or allopurinol), which has a very obvious effect on the prevention and treatment of gastric cancer. The patent was tested in rats, injected with 10mg / kg carcinogen dimethyl hydrazine, the blank group had a normal diet, and the test group drank 10% dimethyl sulfone and 10% dimethyl sulfoxide or 10% dimethyl sulfone and 10% purinol (or allopurinol) every day. After 28 weeks, the blank group was carcinogenic, but no cancer was found in the experimental group, which proved that it had a strong ability to inhibit carcinogenesis. On the fifth day after operation, patients with gastric cancer were given 5ml} 10% dimethyl sulfone and 10% dimethyl sulfoxide solution four times a day. Two years later, the survival number of patients in the treatment group was 46% higher than that in the control group. The survivors continued to take the above solution orally. After four years, 20% of the survivors in the treatment group still survived, while less than 3% of the survivors in the control group. The researchers believe that the gastrointestinal tract of patients with gastric cancer is attacked by oxygen free radicals produced by metabolism, resulting in cell loss and damage and the spread of cancer cells. Dimethyl sulfone and dimethyl sulfoxide enhance each other to remove oxygen free radicals produced by gastric cancer, so as to improve the survival rate.
鲁公网安备 37088202000323号